Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus

Дата публикации: 30-09-2026 00:00:00

This case report describes 2 patients with pemphigus and off-label teclistamab use.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Golidocitinib for Folliculotropic Mycosis Fungoides015.8801-09-2026
2High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation08.1701-09-2026
3Melanoma Prevention Among Children of Melanoma Survivors08.0607-10-2026
4Pseudofolliculitis Barbae Diagnosis and Treatment in US Veterans08.0630-09-2026
5Generalized Linear Keratotic Papules in a Man in His 30s06.3830-09-2026
6Giant Plexiform Neurofibroma in Neurofibromatosis Type 1014.6507-10-2026
7CLIPI and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome08.4807-10-2026
8Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy010.2701-09-2026
9Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma06.2901-09-2026
10Improved Risk Stratification in Mycosis Fungoides and Sézary Syndrome08.9307-10-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 28.92. Источник: archderm.jamanetwork.com.